A Possibility of Vasospastic Angina after mRNA COVID-19 Vaccination

被引:3
作者
Awaya, Toru [1 ]
Moroi, Masao [1 ]
Nakamura, Fuminori [1 ]
Toi, Satoru [1 ]
Wakiya, Momoko [1 ]
Enomoto, Yoshinari [1 ]
Kunimasa, Taeko [1 ]
Nakamura, Masato [1 ]
机构
[1] Toho Univ Ohashi Med Ctr, Dept Cardiovasc Med, 2-22-36 Ohashi Meguro ku, Tokyo 1538515, Japan
关键词
COVID-19; vaccination; cardiovascular diseases; vasospastic angina; adverse reaction; inflammatory cytokine; lipid nanoparticles; angiotensin-converting enzyme 2; alcohol; CORONARY-ARTERY SPASM; RISK;
D O I
10.3390/vaccines10121998
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We report a case of vasospastic angina (VSA) following COVID-19 mRNA vaccination. Despite the widespread occurrence of myocarditis, there have been few reports of post-vaccinal VSA. A 41-year-old male patient was referred for chest pain at rest following mRNA vaccination; he had never experienced chest pain prior to vaccination. He was diagnosed by an acetylcholine (Ach) provocation test that showed multivessel vasospasm. After the initiation of treatment with a calcium channel blocker and nitrate, no further exacerbation of chest pain was observed. To our knowledge, this constitutes the first reported case of VSA proven by Ach provocation test after COVID-19 vaccination. The vaccination may increase coronary artery spasticity. VSA should be ruled out in post-vaccine new onset resting chest pain.
引用
收藏
页数:6
相关论文
共 24 条
[1]   Vasospastic Angina: A Cause of Post-acute COVID-19 Syndrome [J].
Aikawa, Tadao ;
Ogino, Jiro ;
Oyama-Manabe, Noriko ;
Funayama, Naohiro .
INTERNAL MEDICINE, 2022, 61 (17) :2693-2695
[2]   Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses [J].
Alameh, Mohamad-Gabriel ;
Tombacz, Istvan ;
Bettini, Emily ;
Lederer, Katlyn ;
Sittplangkoon, Chutamath ;
Wilmore, Joel R. ;
Gaudette, Brian T. ;
Soliman, Ousamah Y. ;
Pine, Matthew ;
Hicks, Philip ;
Manzoni, Tomaz B. ;
Knox, James J. ;
Johnson, John L. ;
Laczko, Dorottya ;
Muramatsu, Hiromi ;
Davis, Benjamin ;
Meng, Wenzhao ;
Rosenfeld, Aaron M. ;
Strohmeier, Shirin ;
Lin, Paulo J. C. ;
Mui, Barbara L. ;
Tam, Ying K. ;
Kariko, Katalin ;
Jacquet, Alain ;
Krammer, Florian ;
Bates, Paul ;
Cancro, Michael P. ;
Weissman, Drew ;
Prak, Eline T. Luning ;
Allman, David ;
Locci, Michela ;
Pardi, Norbert .
IMMUNITY, 2021, 54 (12) :2877-+
[3]   What Should We Do after the COVID-19 Vaccination? Vaccine-Associated Diseases and Precautionary Measures against Adverse Reactions [J].
Awaya, Toru ;
Moroi, Masao ;
Enomoto, Yoshinari ;
Kunimasa, Taeko ;
Nakamura, Masato .
VACCINES, 2022, 10 (06)
[4]   Acute myocardial infarction and myocarditis following COVID-19 vaccination [J].
Aye, Y. N. ;
Mai, A. S. ;
Zhang, A. ;
Lim, O. Z. H. ;
Lin, N. ;
Ng, C. H. ;
Chan, M. Y. ;
Yip, J. ;
Loh, P-H ;
Chew, N. W. S. .
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2023, 116 (04) :279-283
[5]  
Barbato Emanuele, 2005, Recenti Progressi in Medicina, V96, P411
[6]   International standardization of diagnostic criteria for vasospastic angina [J].
Beltrame, John F. ;
Crea, Filippo ;
Kaski, Juan Carlos ;
Ogawa, Hisao ;
Ong, Peter ;
Sechtem, Udo ;
Shimokawa, Hiroaki ;
Merz, C. Noel Bairey .
EUROPEAN HEART JOURNAL, 2017, 38 (33) :2565-2568
[7]  
Camazón NV, 2022, REV ESP CARDIOL, V75, P444, DOI [10.1016/j.rec.2021.10.010, 10.1016/j.recesp.2021.10.011]
[8]  
Corsini Fabrizio, 2006, Monaldi Arch Chest Dis, V66, P13
[9]   HISTAMINE PROVOCATION OF CLINICAL CORONARY-ARTERY SPASM - IMPLICATIONS CONCERNING PATHOGENESIS OF VARIANT ANGINA-PECTORIS [J].
GINSBURG, R ;
BRISTOW, MR ;
KANTROWITZ, N ;
BAIM, DS ;
HARRISON, DC .
AMERICAN HEART JOURNAL, 1981, 102 (05) :819-822
[10]   COVID-19 Is an Endothelial Disease: Implications of Nitric Oxide [J].
Kidde, Jason ;
Gorabi, Armita Mahdavi ;
Jamialahmadi, Tannaz ;
Sahebkar, Amirhossein .
CLINICAL, BIOLOGICAL AND MOLECULAR ASPECTS OF COVID-19, 2021, 1321 :109-113